drugset / Trial / NCT05727189

A Study of Idazoxan in Healthy Participants

NCT05727189 ↗

Phase 1 Active not recruiting 150 enrolled Terran Biosciences Australia Pty Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

Four-part study of the safety, tolerability and pharmacokinetics of 3 forms of TR-01-XRR, 1 form of TR-01-XRS, and 1 form of TR-01-XR in healthy adults.

Timeline

Start
2023-02-14
Primary completion
2027-12
Completion
2027-12

Drugs

EvaluationDrugModalityDoseRoute
Subject TR-01-IR Unknown — Oral
Subject TR-01-XR Unknown — Oral
Subject TR-01-XRR (1) Unknown — Oral
Subject TR-01-XRR (2) Unknown — —
Subject TR-01-XRR (3) Unknown — —
Subject TR-01-XRS Unknown — Oral

Indications

No indication recorded.